Study of ARQ 197 in Hepatocellular Carcinoma (HCC)
by on Thursday, August 2nd, 2012 | No Comments
Condition: Advanced Hepatocellular Carcinoma
Intervention: Drug: ARQ 197
Sponsors: Kyowa Hakko Kirin Company, Limited; Kyowa Hakko Kirin Company, Limited
Not yet recruiting – verified July 2012
More here: Study of ARQ 197 in Hepatocellular Carcinoma (HCC)